Noninvasive analysis of hepatic glycogen kinetics before and after breakfast with deuterated water and acetaminophen

Detalhes bibliográficos
Autor(a) principal: Jones, John G.
Data de Publicação: 2006
Outros Autores: Fagulha, Ana, Barosa, Cristina, Bastos, Margarida, Barros, Luisa, Baptista, Carla, Caldeira, M. Madalena, Carvalheiro, Manuela
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10316/12711
https://doi.org/10.2337/db06-0304
Resumo: The contributions of hepatic glycogenolysis to fasting glucose production and direct pathway to hepatic glycogen synthesis were quantified in eight type 1 diabetic patients and nine healthy control subjects by ingestion of (2)H(2)O and acetaminophen before breakfast followed by analysis of urinary water and acetaminophen glucuronide. After overnight fasting, enrichment of glucuronide position 5 relative to body water (G5/body water) was significantly higher in type 1 diabetic patients compared with control subjects, indicating a reduced contribution of glycogenolysis to glucose production (38 +/- 3 vs. 46 +/- 2%). Following breakfast, G5/body water was significantly higher in type 1 diabetic patients, indicating a smaller direct pathway contribution to glycogen synthesis (47 +/- 2 vs. 59 +/- 2%). Glucuronide hydrogen 2 enrichment (G2) was equivalent to body water during fasting (G2/body water 0.94 +/- 0.03 and 1.02 +/- 0.06 for control and type 1 diabetic subjects, respectively) but was significantly lower after breakfast (G2/body water 0.78 +/- 0.03 and 0.82 +/- 0.05 for control and type 1 diabetic subjects, respectively). The reduced postprandial G2 levels reflect incomplete glucose-6-phosphate-fructose-6-phosphate exchange or glycogen synthesis from dietary galactose. Unlike current measurements of human hepatic glycogen metabolism, the (2)H(2)O/acetaminophen assay does not require specialized on-site clinical equipment or personnel
id RCAP_8bf6147580f1f31e513055622fe3d766
oai_identifier_str oai:estudogeral.uc.pt:10316/12711
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Noninvasive analysis of hepatic glycogen kinetics before and after breakfast with deuterated water and acetaminophenThe contributions of hepatic glycogenolysis to fasting glucose production and direct pathway to hepatic glycogen synthesis were quantified in eight type 1 diabetic patients and nine healthy control subjects by ingestion of (2)H(2)O and acetaminophen before breakfast followed by analysis of urinary water and acetaminophen glucuronide. After overnight fasting, enrichment of glucuronide position 5 relative to body water (G5/body water) was significantly higher in type 1 diabetic patients compared with control subjects, indicating a reduced contribution of glycogenolysis to glucose production (38 +/- 3 vs. 46 +/- 2%). Following breakfast, G5/body water was significantly higher in type 1 diabetic patients, indicating a smaller direct pathway contribution to glycogen synthesis (47 +/- 2 vs. 59 +/- 2%). Glucuronide hydrogen 2 enrichment (G2) was equivalent to body water during fasting (G2/body water 0.94 +/- 0.03 and 1.02 +/- 0.06 for control and type 1 diabetic subjects, respectively) but was significantly lower after breakfast (G2/body water 0.78 +/- 0.03 and 0.82 +/- 0.05 for control and type 1 diabetic subjects, respectively). The reduced postprandial G2 levels reflect incomplete glucose-6-phosphate-fructose-6-phosphate exchange or glycogen synthesis from dietary galactose. Unlike current measurements of human hepatic glycogen metabolism, the (2)H(2)O/acetaminophen assay does not require specialized on-site clinical equipment or personnelAmerican Diabetes Association2006-08info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/12711http://hdl.handle.net/10316/12711https://doi.org/10.2337/db06-0304engDiabetes. 55:8 (2006) 2294-23000012-1797Jones, John G.Fagulha, AnaBarosa, CristinaBastos, MargaridaBarros, LuisaBaptista, CarlaCaldeira, M. MadalenaCarvalheiro, Manuelainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2020-11-06T17:00:26Zoai:estudogeral.uc.pt:10316/12711Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:55:48.326014Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Noninvasive analysis of hepatic glycogen kinetics before and after breakfast with deuterated water and acetaminophen
title Noninvasive analysis of hepatic glycogen kinetics before and after breakfast with deuterated water and acetaminophen
spellingShingle Noninvasive analysis of hepatic glycogen kinetics before and after breakfast with deuterated water and acetaminophen
Jones, John G.
title_short Noninvasive analysis of hepatic glycogen kinetics before and after breakfast with deuterated water and acetaminophen
title_full Noninvasive analysis of hepatic glycogen kinetics before and after breakfast with deuterated water and acetaminophen
title_fullStr Noninvasive analysis of hepatic glycogen kinetics before and after breakfast with deuterated water and acetaminophen
title_full_unstemmed Noninvasive analysis of hepatic glycogen kinetics before and after breakfast with deuterated water and acetaminophen
title_sort Noninvasive analysis of hepatic glycogen kinetics before and after breakfast with deuterated water and acetaminophen
author Jones, John G.
author_facet Jones, John G.
Fagulha, Ana
Barosa, Cristina
Bastos, Margarida
Barros, Luisa
Baptista, Carla
Caldeira, M. Madalena
Carvalheiro, Manuela
author_role author
author2 Fagulha, Ana
Barosa, Cristina
Bastos, Margarida
Barros, Luisa
Baptista, Carla
Caldeira, M. Madalena
Carvalheiro, Manuela
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Jones, John G.
Fagulha, Ana
Barosa, Cristina
Bastos, Margarida
Barros, Luisa
Baptista, Carla
Caldeira, M. Madalena
Carvalheiro, Manuela
description The contributions of hepatic glycogenolysis to fasting glucose production and direct pathway to hepatic glycogen synthesis were quantified in eight type 1 diabetic patients and nine healthy control subjects by ingestion of (2)H(2)O and acetaminophen before breakfast followed by analysis of urinary water and acetaminophen glucuronide. After overnight fasting, enrichment of glucuronide position 5 relative to body water (G5/body water) was significantly higher in type 1 diabetic patients compared with control subjects, indicating a reduced contribution of glycogenolysis to glucose production (38 +/- 3 vs. 46 +/- 2%). Following breakfast, G5/body water was significantly higher in type 1 diabetic patients, indicating a smaller direct pathway contribution to glycogen synthesis (47 +/- 2 vs. 59 +/- 2%). Glucuronide hydrogen 2 enrichment (G2) was equivalent to body water during fasting (G2/body water 0.94 +/- 0.03 and 1.02 +/- 0.06 for control and type 1 diabetic subjects, respectively) but was significantly lower after breakfast (G2/body water 0.78 +/- 0.03 and 0.82 +/- 0.05 for control and type 1 diabetic subjects, respectively). The reduced postprandial G2 levels reflect incomplete glucose-6-phosphate-fructose-6-phosphate exchange or glycogen synthesis from dietary galactose. Unlike current measurements of human hepatic glycogen metabolism, the (2)H(2)O/acetaminophen assay does not require specialized on-site clinical equipment or personnel
publishDate 2006
dc.date.none.fl_str_mv 2006-08
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10316/12711
http://hdl.handle.net/10316/12711
https://doi.org/10.2337/db06-0304
url http://hdl.handle.net/10316/12711
https://doi.org/10.2337/db06-0304
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Diabetes. 55:8 (2006) 2294-2300
0012-1797
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv American Diabetes Association
publisher.none.fl_str_mv American Diabetes Association
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133844276772864